Cannabis and cannabinoids for symptomatic treatment for people with multiple sclerosis. Cochrane Database Syst Rev. 2022

Βιβλιοθήκη Open Access Δημοσιεύσεων Εκπαίδευση Επιστημονικό υλικό
eiek.gr

Filippini G, Minozzi S, Borrelli F, Cinquini M, Dwan K. Cannabis and cannabinoids for symptomatic treatment for people with multiple sclerosis. Cochrane Database Syst Rev. 2022 May 5;5(5):CD013444. doi: 10.1002/14651858.CD013444.pub2. PMID: 35510826; PMCID: PMC9069991.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9069991/

Σχετικά άρθρα

Therapeutic Potential of Cannabis: A Comprehensive Review of Current and Future Applications. Biomedicines. 2023

eiek.gr

Balancing risks and benefits of cannabis use: umbrella review of meta-analyses of randomised controlled trials and observational studies. BMJ 2023

eiek.gr

Improved Post-Traumatic Stress Disorder Symptoms and Related Sleep Disturbances after Initiation of Medical Marijuana Use: Evidence froma Prospective Single Arm Pilot Study. Med Cannabis Cannabinoids. 2023 Nov

eiek.gr